Medication info
TruEmpagliflozin 25/5 mg Tablet (Empagliflozin, Linagliptin)

TruEmpagliflozin 25/5 mg Tablet (Empagliflozin, Linagliptin)

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin›25mg / 1 tabletLinagliptin›5mg / 1 tablet
Manufacturer / importer
Boryung Pharmaceutical Co., Ltd.
Appearance
Pale pink, convex, round film-coated tablet
Packaging
30 tablets/box [(10 tablets/PTP x 3)]
Approval status
Active

MFDS item code 202502389 · Approved 2025.09.09

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended starting dose of this medicine is empagliflozin 10 mg/linagliptin 5 mg once daily. If empagliflozin 10 mg/linagliptin 5 mg is tolerated and additional glycemic control is needed, the dose of this medicine may be increased to 25/5 mg once daily. Patients switching to this medicine from concomitant therapy with empagliflozin and linagliptin should receive their previous doses. This medicine may be taken with or without food. Swallow the tablet whole. If a dose is missed, take it as soon as remembered. However, if the next dose is due within 12 hours, skip the missed dose and take the next dose at the usual scheduled time. Do not take a double dose in one day. Patients with renal impairment This medicine is not recommended for patients with an estimated glomerular filtration rate (eGFR) below 45 ml/min/1.73m2 for the purpose of improving glycemic control. No dose adjustment is necessary in patients with an estimated glomerular filtration rate of 45 ml/min/1.73m2 or higher. Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. Elderly patients No dose adjustment based on age is necessary. Renal function and the risk of volume depletion should be considered in patients aged 75 years and older.

Ingredients

Manufacturer
Boryung Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

View approved original text

This medication is used in conjunction with dietary and exercise therapy to help control blood sugar in patients with type 2 diabetes. The combination of empagliflozin and linagliptin effectively aids in improving blood sugar levels.

How to take

Adult dose

The recommended starting dose of this medicine is empagliflozin 10 mg/linagliptin 5 mg once daily. If empagliflozin 10 mg/linagliptin 5 mg is tolerated and additional glycemic control is needed, the dose of this medicine may be increased to 25/5 mg once daily. Patients switching to this medicine from concomitant therapy with empagliflozin and linagliptin should receive their previous doses. This medicine may be taken with or without food. Swallow the tablet whole. If a dose is missed, take it as soon as remembered. However, if the next dose is due within 12 hours, skip the missed dose and take the next dose at the usual scheduled time. Do not take a double dose in one day. Patients with renal impairment This medicine is not recommended for patients with an estimated glomerular filtration rate (eGFR) below 45 ml/min/1.73m2 for the purpose of improving glycemic control. No dose adjustment is necessary in patients with an estimated glomerular filtration rate of 45 ml/min/1.73m2 or higher. Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. Elderly patients No dose adjustment based on age is necessary. Renal function and the risk of volume depletion should be considered in patients aged 75 years and older.

Precautions

This medication contains two ingredients, empagliflozin and linagliptin. It is used to assist in blood sugar control in patients with type 2 diabetes. This medication should not be used in certain patients. For example, individuals with an allergy to any of the components, patients with type 1 diabetes, those with diabetic ketoacidosis, and patients undergoing dialysis should not take this medication. Patients with impaired kidney function should regularly undergo renal function tests before taking this medication, and patients with heart failure should also use it with caution. Additionally, if symptoms such as acute pancreatitis or bullous pemphigoid (blistering skin disease) occur while taking this medication, the medication should be stopped immediately and a doctor should be consulted. The most common side effect when taking this medication is urinary tract infection, although rare side effects may include ketoacidosis, pancreatitis, allergic reactions, and hypoglycemia. The risk of hypoglycemia may be heightened, especially when this medication is taken in conjunction with insulin or sulfonylureas, and caution is required. Fluid volume depletion or hypotension may occur, so patients who are being treated for hypertension or have low blood pressure, as well as elderly individuals over 75 years old, should exercise special caution when taking this medication. This medication may also increase the risk of genital fungal infections, so appropriate treatment may be necessary if related symptoms arise. Extra caution is needed when driving or operating machinery due to the risk of hypoglycemia. It is advisable for women who are pregnant or breastfeeding to avoid using this medication, and it is recommended that children under the age of 18 do not take it as its safety and efficacy have not been established. There is no specific antidote for overdose, so appropriate treatment should be administered according to symptoms, and this medication should be stored in its original container in a safe place out of the reach of children.

Side effects

  • urinary tract infection
  • vaginitis
  • vulvitis
  • balanitis
  • other genital infections
  • hypersensitivity
  • angioedema
  • hives
  • hypoglycemia
  • thirst
Show 197 more
  • ketoacidosis
  • cough
  • constipation
  • pancreatitis
  • oral ulcer formation
  • itching
  • rash
  • vesicular pemphigoid
  • rhabdomyolysis
  • hypovolemia
  • increased urination
  • urinary retention
  • interstitial nephritis
  • increased amylase
  • increased lipase
  • increased hematocrit
  • increased serum lipids
  • increased blood creatinine
  • decreased glomerular filtration rate
  • epigastric pain
  • enterocolitis
  • intestinal obstruction
  • gastritis
  • shingles
  • cystitis
  • acute pyelonephritis
  • bronchitis
  • vestibular neuronitis
  • sepsis
  • pneumonia
  • decreased appetite
  • dehydration
  • hyperglycemia
  • cerebral infarction
  • speech disorder
  • Alzheimer's disease
  • chest pain
  • fever
  • facial swelling
  • fatigue
  • death
  • chronic obstructive pulmonary disease
  • asthma
  • diabetic foot
  • skin lesions
  • acute kidney injury
  • end-stage renal disease
  • acute cholangitis
  • acute cholecystitis
  • cholangitis
  • dizziness
  • kidney transplant failure
  • abdominal pain
  • gastrointestinal disorders
  • irritable bowel syndrome
  • burning mouth syndrome
  • colitis
  • abdominal discomfort
  • dysphagia
  • gastric ulcer
  • gum bleeding
  • tooth loss
  • hemorrhoids
  • lower abdominal pain
  • diarrhea
  • vomiting
  • gastritis
  • leukoplakia
  • rhinitis
  • soft tissue infection
  • pharyngitis
  • scrub typhus
  • periodontitis
  • tonsillitis
  • laryngitis
  • viral upper respiratory infection
  • tonsillitis
  • headache
  • orthostatic dizziness
  • sensory loss
  • sensory disturbance
  • amnesia
  • carotid artery stenosis
  • facial paralysis
  • memory disturbance
  • neuralgia
  • Parkinsonism
  • polyneuropathy
  • sensory impairment
  • drowsiness
  • CNS-origin vertigo
  • peripheral edema
  • facial swelling
  • peripheral swelling
  • chills
  • strange sensation
  • edema
  • pain at the puncture site
  • vascular stent stenosis
  • vascular stent thrombosis
  • weight gain
  • electrocardiogram abnormalities
  • hemoglobin decrease
  • hemoglobin increase
  • Helicobacter test positive
  • urine erythrocytes positive
  • ureterolithiasis
  • hematuria
  • renal mass
  • urinary retention
  • vaginal discharge
  • hypoglycemia
  • decreased appetite
  • obesity
  • acanthosis
  • diabetes
  • hyperlipidemia
  • hyponatremia
  • vitamin D deficiency
  • dermal cyst
  • seborrheic dermatitis
  • atopic dermatitis
  • nummular eczema
  • heat rash
  • sebaceous gland hyperplasia
  • lumbar spinal canal stenosis
  • myalgia
  • limb pain
  • musculoskeletal chest pain
  • arthralgia
  • cervical stenosis
  • fibromyalgia
  • flank pain
  • fracture pain
  • muscle weakness
  • osteoarthritis
  • osteoporosis
  • rotator cuff syndrome
  • astigmatism
  • allergic conjunctivitis
  • blurred vision
  • corneal abrasion
  • macular fibrosis
  • eye discomfort
  • eye congestion
  • pathological myopia
  • retinal detachment
  • retinal crystal
  • retinal vein occlusion
  • lattice retinal detachment
  • eyelid swelling
  • visual impairment
  • vitreous floaters
  • vitreous hemorrhage
  • epistaxis
  • exertional dyspnea
  • wet cough
  • allergic rhinitis
  • sputum retention
  • skin laceration
  • rib fracture
  • long ligament syndrome
  • angina
  • palpitations
  • Prinzmetal angina
  • coronary artery disease
  • tachycardia
  • atherosclerosis
  • deep vein thrombosis
  • diabetic vascular complications
  • peripheral arterial occlusive disease
  • anxiety
  • depression
  • sleep disorders
  • acute cholecystitis
  • autoimmune hepatitis
  • cholelithiasis
  • hepatitis
  • otalgia
  • postural dizziness
  • dizziness
  • anemia
  • lymphadenopathy
  • hypothyroidism
  • thyroid nodules
  • constipation
  • chest discomfort
  • weakness
  • weight loss
  • vulvar pruritus
  • genital pruritus
  • dyslipidemia
  • dry eyes
  • dyspnea
  • unstable angina
  • hypertension
  • insomnia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to protect it from air and moisture. It is important to maintain storage temperatures between 1 and 30 degrees Celsius. Proper storage will help maintain the effectiveness and safety of the medication.

Appearance and packaging

Appearance

Pale pink, convex, round film-coated tablet

Package unit

30 tablets/box [(10 tablets/PTP x 3)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.